RemoteLeads seeks a US-based biotech investment analyst to create and critique rubrics for evaluating drugs and development programs. You will assess mechanisms, clinical data, competitive positioning and value drivers across 5–10 companies.
This remote role is part-time for a 10–20 hour pilot over 1–2 weeks, with compensation of $120–$200 per hour and potential for recurring work as the engagement scales.
#J-18808-LjbffrBiotech Investment Analyst Remote Drug Evaluation in workfromhome at Unknown Company
This position is listed as part time and able to be worked remotely.